IMC 9.09% 10.0¢ immuron limited

Ann: Travelan to progress to Phase 3 Clinical Trials in the US, page-49

  1. 54 Posts.
    lightbulb Created with Sketch. 2
    Totally agree with you but look at NYR that went up 4 folds, yes lower MC on Phase 1 mice
    We have a viable product currently OTC at most pharmaceutical branches and were under 20MC.

    Were talking 15M in bank i cant see them running out in a month
 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.